Cyclacel Pharmaceuticals Inc (CYCC) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Yahoo Finance · 2 days ago
Open | 2.2800 |
High | 2.3985 |
Low | 2.2310 |
Mkt Cap | 3.43M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 2.3400 |
52 Wk. Low | 1.3000 |
52 Wk. High | 13.2000 |
Related stocks
Company in Berkeley Heights, United States
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Berkeley Heights, New Jersey and Dundee, Scotland, developing cancer treatments. Cyclacel was founded in 1996 by David Lane, PhD. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 31k | - |
Net Income | -5.27M | - |
Diluted EPS | -2.27 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$1.69 | - |
Q1 2024 | -$4.74 | -$2.27 |
Q4 2023 | -$5.89 | -$6.23 |
S&P 500^GSPC | 5,301.13+4.03 (+0.08%) |
Dow 30^DJI | 39,960.99+91.61 (+0.23%) |
Nasdaq^IXIC | 16,683.86-14.46 (-0.09%) |
Reddit, Inc.RDDT | 62.28+10.46% |
1.1450-30.70% | |
20.00+11.71% |